Mexedrone

Add links
Source: Wikipedia, the free encyclopedia.
Mexedrone
Legal status
Legal status
Identifiers
  • 3-Methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one
JSmol)
  • Cc1ccc(cc1)C(=O)C(COC)NC
  • InChI=1S/C12H17NO2/c1-9-4-6-10(7-5-9)12(14)11(13-2)8-15-3/h4-7,11,13H,8H2,1-3H3
  • Key:JHGDCSPZKQLBOP-UHFFFAOYSA-N

Mexedrone (also known as 4-MMC-MeO) is a

class that has been sold online as a designer drug.[1][2][3][4] It is the alpha-methoxy derivative of Mephedrone
.

Pharmacology

Mexedrone acts as a weak serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) with IC50 values of 5289 nM, 8869 nM and 6844 nM, respectively, as well as a weak serotonin releasing agent (SRA) with an EC50 value of 2525 nM.[5]

Legal status

Mexedrone is illegal in Sweden as of January 26, 2016[6] as well as Japan as of August 24, 2016.[7]

See also

References

  1. ^ "Mexedrone". New Synthetic Drug Database.
  2. PMID 27352812
    .
  3. hdl:20.500.12128/9638
    .
  4. S2CID 33220365
    .
  5. PMID 27524685
    .
  6. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
  7. ^ "指定薬物一覧" (PDF) (in Japanese). Ministry of Health, Labour and Welfare.
drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Mexedrone&oldid=1193763514"